Department of Heavy Ion Radiation Medicine, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Cell Cycle. 2013 Jun 15;12(12):1861-7. doi: 10.4161/cc.24967. Epub 2013 Jun 13.
p73, has two distinct promoters, which allow the formation of two protein isoforms: full-length transactivating (TA) p73 and an N-terminally truncated p73 species (referred to as DNp73) that lacks the N-terminal transactivating domain. Although the exact cellular function of DNp73 is unclear, the high expression levels of the genes have been observed in a variety of human cancers and cancer cell lines and have been connected to pro-tumor activities. Hence the aim of this review is to summarize DNp73 expression status in cancer in the current literature. Furthermore, we also focused on recent findings of DNp73 related to the biological functions from apoptosis, chemosensitivity, radiosensitibity, differentiation, development, etc. Thus this review highlights the significance of DNp73 as a marker for disease severity in patients and as target for cancer therapy.
p73 有两个不同的启动子,这允许形成两种蛋白质异构体:全长转录激活(TA)p73 和 N 端截断的 p73 种(称为 DNp73),其缺乏 N 端转录激活结构域。尽管 DNp73 的确切细胞功能尚不清楚,但在各种人类癌症和癌细胞系中观察到高表达水平,并与促肿瘤活性有关。因此,本综述的目的是总结当前文献中癌症中 DNp73 的表达状况。此外,我们还关注了最近关于 DNp73 与细胞凋亡、化学敏感性、放射敏感性、分化、发育等生物学功能相关的发现。因此,本综述强调了 DNp73 作为患者疾病严重程度标志物和癌症治疗靶点的重要性。